• Cartesian Therapeutics granted a new employee an option to purchase 50,000 common shares on November 2, 2026.
• The option carries an exercise price of $6.34 and a 10-year term.
• Vesting starts at 25% on November 2, 2027, followed by 36 substantially equal monthly installments through November 2, 2030.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cartesian Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611030700PRIMZONEFULLFEED9868535) on November 03, 2026, and is solely responsible for the information contained therein.